donation
To request Mental Health
Services or to access Mental
Health Crisis Services Call:
1-800-375-4357

Medical Disorders
Resources
Basic InformationLookupsLatest News
High-Tech Exoskeletons Improve Bowel Function in People With Spinal Cord Injury'Superbug' Fungus Spreads Among Vulnerable in Two U.S. CitiesVaccinations Start to Climb in States Hit Hard by Delta VariantBiden Says Full Approval for COVID Vaccines Coming SoonPfizer Vaccine Offers 88% Protection Against Delta Variant, But 2 Doses NeededSecret Weapon: Why the 2nd Dose of Pfizer Vaccine Is So CrucialCOVID Drove Biggest Drop in U.S. Life Expectancy Since World War IIJ&J Vaccine Weak Against Delta Variant, 2nd Dose May Be NeededDouble Trouble: Wildfire Smoke Could Boost Odds for COVID's SpreadStatin Users May Have Added Protection Against Severe COVID-19One-Dose Blood Thinner Could Slash Blood Clot Risk After Knee ReplacementU.S. Issues Toughest Travel Alert for Britain As COVID Cases There ClimbPediatricians' Group: All School Kids, Staff Should Continue to Wear MasksAny COVID Infection Leaves Strong Antibody Levels in KidsMany Hit Hard by Pandemic Now Swamped by Medical DebtU.S. Surgeon General Backs Local Mask Mandates When NeededMake Summer Camp Safe for Your Child With Asthma, AllergiesCanada May Open Borders to Fully Vaccinated Americans by Mid-AugustCDC Advisors to Discuss 3rd COVID Vaccine Dose for ImmunocompromisedFDA to Prioritize Full Approval for Pfizer COVID VaccineEven a Little Lead in Drinking Water Can Harm People With Kidney DiseaseStatin's Health Benefits Far Outweigh  Any Potential Harms: StudyMore Than a Quarter of Long COVID Patients Still Not Recovered After 6 MonthsWhy Many Black & Hispanic Americans Distrust COVID VaccinesU.S. Surgeon General Issues Call to Counter 'Urgent Threat' of Vaccine MisinformationFriends, Family Key to Turning a 'No' on Vaccination to a 'Yes'AHA News: How Healthy Is Your Neighborhood? Where You Live Can Greatly Affect Heart, Brain HealthHeart Troubles Ease Over Time in Kids With MIS-CUltra-Processed Foods Might Help Drive Inflammatory Bowel DiseaseHalf of U.S. Teens Plan to Get COVID Shot, But Can Numbers Go Higher?Many States Move to Ban Vaccine Mandates, Passports in Public SchoolsBusted Ankle? What's Better, a Cast or Brace?New COVID Cases Double in U.S. in Past Three WeeksAmericans With Diabetes Were Hit Hard by COVID PandemicAHA News: The Challenge of Diabetes in the Black Community Needs Comprehensive SolutionsInhaled COVID Vaccine Shows Promise in Animal TrialsFlu Shot Might Help Ward Off Severe COVIDAdults With ADHD May Face Higher Odds for Physical Illnesses: StudyBlack Churches Could Be Key to Boosting Vaccination RatesSome COVID Survivors Can't Regain Weight Lost During IllnessFDA Set to Add Guillain-Barre Warning to J&J COVID VaccineU.S. COVID Vaccine Rollout Saved 279,000 Lives: StudyVaccinated Teachers, Students Can Skip Masks This Fall: CDCYour Job Could Put You at Much Higher Risk for FluGlobal Consortium Finds Genes That Drive Severe COVID-19More Air Pollution, Worse COVID Outcomes?Even Before Pandemic, One-Third of U.S. Adults Went Without Dental CarePfizer to Seek Approval for Booster COVID Shot, But U.S. Agencies Balk at TimingU.S. Deaths From Cancer Continue to DeclineDepression Plagues Many Coal Miners With Black Lung Disease
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Antibiotics Won't Help Fight Lung-Scarring Disease IDF: Study

HealthDay News
by Robert Preidt
Updated: Jun 7th 2021

new article illustration

MONDAY, June 7, 2021 (HealthDay News) -- Antibiotics do not reduce the risk of hospitalization or death in patients with a lethal lung disease known as idiopathic pulmonary fibrosis, a new study finds.

"We were certainly disappointed in the results," said study co-author Dr. Imre Noth, chief of pulmonary and critical care medicine at UVA Health in Charlottesville, Va. "But we remain hopeful that in further downstream analyses, we may yet find groups of patients that were potentially benefiting. In the meantime, this study will make sure that no one takes antibiotics without need."

Idiopathic pulmonary fibrosis (IPF) causes scar tissue to build up in the lungs over time, preventing them from providing the body with sufficient oxygen. It usually affects people over 50, mostly men. Most live only two to five years after diagnosis.

The cause is unknown, but environmental and genetic factors, as well as lung infections, may play a role. Previous research has suggested that antibiotics might help.

To find out if that's true, researchers in 35 U.S. sites conducted a clinical trial with 513 patients, age 40 or older. Half received antibiotics (either co-trimoxazol or doxycycline); the rest received standard care.

After a median followup of 12.7 months (meaning half were followed longer, half for less time), there was no statistically significant difference between the two groups in breathing-related hospitalization or death, according to findings recently published in the Journal of the American Medical Association.

A previous study yielded similar findings, and authors of the new study say their results confirm that antibiotics should not be used as a general treatment for IPF.

However, they didn't rule out that antibiotics may benefit a small number of patients with known disruptions to their populations of microorganisms in their lungs.

"As the largest single study in IPF ever conducted, I think we are going to learn a lot as we look at things more closely," Noth said in a UVA news release. "Might our choice of antibiotics have been the right ones? Were there some patients that did better than others? Who should we be targeting for treatment? All things this study will help in the future."

More information

The U.S. National Heart, Lung, and Blood Institute has more on idiopathic pulmonary fibrosis.


SOURCE: UVA Health, news release, June 22, 2021